FDA amends opioid action warning

Share this article:
The Food and Drug Administration will temporarily allow the continued production, marketing and distribution of one particular type of opioid, which is widely used to alleviate pain in terminally ill patients.

The action is in response to a March 30 warning that it issued to manufacturers to stop producing certain unapproved prescription opioids.  Concerns from palliative care patients and healthcare professionals prompted the FDA to amend the warning. They were concerned that the original order would cause a shortage of morphine sulfate oral solution.

The agency has determined that the 20 milligram dosage form of morphine sulfate oral solution is medically necessary and should remain on the market until an approved alternative becomes available.

Share this article:

More in News

Nursing home administrators do not believe that pay-for-performance improves care quality or facility profitability, survey shows

Nursing home administrators do not believe that pay-for-performance ...

Most nursing home administrators do not believe that pay-for-performance initiatives lead to improved resident care or stronger bottom lines, according to findings recently published in the Journal of Aging and ...

Former CNA gets 16-year prison sentence for stealing nursing home residents' identities

Three former nursing home aides are facing prison time for stealing residents' identities and conning the government, state and federal authorities announced Thursday.

Aggression strongly signals pain only when dementia reaches advanced stages, researchers find

For a person with dementia, the link between aggressive behavior and physical pain is strong only in the condition's advanced stages, University of Florida researchers have found.